Cerba Research offers state-of-the-art genomic technologies to obtain the essential dataset from your liquid tumors, such as multiple myeloma, acute myeloid leukemia, myeloproliferative neoplasms, and more.
Next Generation Sequencing Capabilities for Liquid Tumours
Cerba Research is proud to offer a full range of next-generation sequencing capabilities for your liquid tumors clinical trial specimens.
We have broad panel assays to cover indications such as myeloproliferative syndrome, acute myeloid leukemia, myeloid tumors, lymphoproliferative syndromes and more.
Discover how we can help you to unlock the genomics information from your liquid tumor specimens.
Cerba Paris Comprehensive Hematological Malignancies Panels
| Panel Name | Genes | Tumor Type | Instrument | TAT | Bone marrow | Peripheral blood | FFPE |
|---|---|---|---|---|---|---|---|
|
MPN Panel |
15 |
Myeloproliferative neoplasms |
NextSeq |
15 |
X |
X |
|
|
MDS/CMML Panel |
32 |
Myelodysplastic syndromes, CMML |
NextSeq |
15 |
X |
X |
|
|
AML Panel |
36 |
Acute myeloid leukemia |
NextSeq |
15 |
X |
X |
|
|
Pan-myeloid Panel AML / MDS / CMML / MPN |
40 |
Myeloid tumors, CMML, MDS |
NextSeq |
15 |
X |
X |
|
|
Mature Lymphoid Panel |
10 |
Lymphoproliferative syndromes |
NextSeq |
15 |
X |
X |
| Panel Name | |
|---|---|
| Genes |
15 |
| Tumor Type |
Myeloproliferative neoplasms |
| Instrument |
NextSeq |
| TAT |
15 |
| Bone marrow |
X |
| Peripheral blood |
X |
| FFPE | |
| Panel Name | |
|---|---|
| Genes |
32 |
| Tumor Type |
Myelodysplastic syndromes, CMML |
| Instrument |
NextSeq |
| TAT |
15 |
| Bone marrow |
X |
| Peripheral blood |
X |
| FFPE | |
| Panel Name | |
|---|---|
| Genes |
36 |
| Tumor Type |
Acute myeloid leukemia |
| Instrument |
NextSeq |
| TAT |
15 |
| Bone marrow |
X |
| Peripheral blood |
X |
| FFPE | |
| Panel Name | |
|---|---|
| Genes |
40 |
| Tumor Type |
Myeloid tumors, CMML, MDS |
| Instrument |
NextSeq |
| TAT |
15 |
| Bone marrow |
X |
| Peripheral blood |
X |
| FFPE | |
| Panel Name | |
|---|---|
| Genes |
10 |
| Tumor Type |
Lymphoproliferative syndromes |
| Instrument |
NextSeq |
| TAT |
15 |
| Bone marrow |
X |
| Peripheral blood |
X |
| FFPE | |
Cerba Research Liquid Tumor NGS Landscape
Benefit from our capabilities and expertise to obtain the dataset you need for your liquid tumor clinical trial
A full range of gene panels available
Myelo proliferative neoplasms
Chronic Myelomonosystic leukemia and myelodysplasic syndroms
Acute Myeloblastic leukemia
Lymphoid malignancies
BCR-ABL
AML1-ETO / RUNX1 – RUNX1T1
PML-RARA
CBFB – MYH11
JAK2 V617F
MYD88
All hematological malignancies
B/T Clonality
AML/MPNs Analysis
Our Latest Content on Hematological Malignancies
Reach out to our genomics team and see how we can help advance your research with our Hematological Malignancies NGS capabilities
Contact Us